Tonghua Dongbao Pharmaceutical Co., Ltd.
SHH: 600867.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Chun Sheng Leng
- Employees
- 3,410
- Headquarters
- Tonghua, China
- IPO year
- 1994
- Market cap
- CN¥17.8B
- Website
- https://www.thdb.com
Loading 600867…
Loading profile data…Frequently asked questions about 600867
What does Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) do?
Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical products for the treatment of diabetes and cardiovascular-based diseases in China. The company operates through Pharmaceutical Industry and Building Materials Industry segments. Its lead product portfolio includes insulin analogues, such as i...
Where does 600867.SS trade?
Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) trades on the Shanghai Stock Exchange.
What sector is 600867.SS in?
Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Tonghua Dongbao Pharmaceutical Co., Ltd.?
Chun Sheng Leng is the chief executive officer of Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS).
Where is Tonghua Dongbao Pharmaceutical Co., Ltd. headquartered?
Tonghua Dongbao Pharmaceutical Co., Ltd. is headquartered in China.
Does 600867.SS pay a dividend?
Yes — Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) paid a trailing twelve-month dividend of CNY 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600867.SS go public?
Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS) completed its initial public offering in 1994.